LBA23 EPIK-P1: Retrospective chart review study of patients (pts) with PIK3CA-related Overgrowth Spectrum (PROS) who have received alpelisib (ALP) as part of a compassionate use programme
Authors:
- G. CanaudGCG. Canaud
- J.C. López GutiérrezJGJ.C. López Gutiérrez
- A. IrvineAIA. Irvine
- N. AnkrahNAN. Ankrah
- A. PapadimitriouAPA. Papadimitriou
- A. RidolfiARA. Ridolfi
- D.M. AdamsDAD.M. Adams
- 1 September 2021
- journal article
- abstracts
- Published by Elsevier in Annals of Oncology
- Vol. 32, S1297
Abstract
No abstract availableFunding Information
- Novartis Pharmaceuticals Corporation